[The ototoxicity of the aminoglycoside antibiotics (author's transl)].
D000284:Administration, Oral; D000617:Aminoglycosides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity*; D003051:Cochlea / Q000187:drug effects; D007758:Ear, Inner / Q000187:drug effects*; D006168:Guinea Pigs; D006207:Half-Life; D006801:Humans; D007612:Kanamycin / Q000378:metabolism; D007761:Labyrinthine Fluids / Q000032:analysis; D009925:Organ of Corti / Q000166:cytology / Q000187:drug effects; D012996:Solutions
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D012996:Solutions; D007612:Kanamycin
Zur Ototoxizität der Aminoglykosid-Antibiotika.